First in human clinical development of the MC4 receptor antagonist scFv 1E8a (Obexia) - MFZ 2010_012
Nov 10, 2010
For patients with cancer cachexia new mechanism-based pharmacological interventions are required, in addition to a standardized palliative cancer care and basic cachexia management approach. The melanocortin system is one of the important targets for...
Clinical Studies -
Nov 10, 2010 - Dec 31, 2011
Aborted
Project leader: Jörger Markus, Strasser Florian
Members: Haile Sarah, Hundsberger Tom
more